LEO Pharma: all 254 studies

Page 3 of 3. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.

• Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic KeratosisCompletedNCT01214564Phase 2
• LEO 22811 - Single Dose Bioavailability Study of Tablet Versus Oral Solution in Healthy SubjectsCompletedNCT01211964Phase 1
• LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism PatientsCompletedNCT01167309Phase 1
• LEO 27847 - Single Dose Bioavailability Study of Oral Solution Versus Tablet in Healthy SubjectsCompletedNCT01143298Phase 1
• The Impact of Renal Impairment on the Pharmacokinetic and Pharmacodynamic of LEO 27847CompletedNCT01141179Phase 1
• Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in CancerCompletedNCT01130025Phase 3
• A Psoriasis Plaque Test Comparing Eight Different Formulations of Vitamin D Analogues for the Treatment of PsoriasisCompletedNCT01105286Phase 1
• An Irritation Study With New Calcipotriol Ointment Formulations in Healthy SubjectsCompletedNCT01105234Phase 1
• Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)CompletedNCT01052467
• A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis VulgarisCompletedNCT01043224Phase 1
• LEO 27847 - A Study in Healthy Male SubjectsCompletedNCT01007383Phase 1
• A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic DermatitisCompletedNCT01005823Phase 1
• A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 StudyCompletedNCT00989313
• Assessment of the Phototoxic Potential of LEO 29102 CreamCompletedNCT00958516Phase 1
• A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 StudiesCompletedNCT00953732
• A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 StudyCompletedNCT00952783
• A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)CompletedNCT00917306Phase 3
• LEO 29102 Single and Multiple Dose Study by Dermal ApplicationCompletedNCT00891709Phase 1
• A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy VolunteersCompletedNCT00850811Phase 1
• A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy VolunteersCompletedNCT00850681Phase 1
• LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy SubjectsCompletedNCT00833872Phase 1
• Efficacy and Safety of 3 Doses of HL10 Given at Fixed Time Intervals Compared to Standard TherapyTerminatedNCT00742482Phase 3
• Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of MycosesCompletedNCT00722189
• Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2CompletedNCT00659893Phase 1
• The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s)WithdrawnNCT00546611Phase 1
• A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the HandCompletedNCT00544297Phase 2
• Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005CompletedNCT00544258Phase 1
• A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic DermatitisTerminatedNCT00475605
• To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCCCompletedNCT00432185Phase 2
• A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical GelCompletedNCT00427050Phase 2
• A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once DailyCompletedNCT00417937Phase 4
• A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the FaceCompletedNCT00408330Phase 2
• LEO19123 Cream in the Treatment of Hand EczemaCompletedNCT00404196Phase 2
• A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral DermatitisCompletedNCT00403949Phase 2
• LEO19123 Cream in the Treatment of Atopic DermatitisCompletedNCT00392067Phase 2
• Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic KeratosesCompletedNCT00375739Phase 2
• Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Patch Test DesignCompletedNCT00357916Phase 1
• Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In SituCompletedNCT00329121Phase 2
• Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in PsoriasisCompletedNCT00279162Phase 3
• Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis VulgarisCompletedNCT00263718Phase 2
• Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis VulgarisCompletedNCT00248456Phase 4
• Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp PsoriasisCompletedNCT00243464Phase 3
• Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical GelCompletedNCT00239135Phase 2
• Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis VulgarisCompletedNCT00216892Phase 4
• Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp PsoriasisCompletedNCT00216879Phase 3
• Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp PsoriasisCompletedNCT00216840Phase 3
• Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp PsoriasisCompletedNCT00216827Phase 3
• Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic DermatitisCompletedNCT00185510Phase 4
• Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell CarcinomaCompletedNCT00108134Phase 2
• Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell CarcinomaCompletedNCT00108121Phase 2
• Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic KeratosesCompletedNCT00107965Phase 2
• Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular CarcinomaTerminatedNCT00051545Phase 3
• Seocalcitol Versus Placebo in Advanced Hepatocellular CarcinomaTerminatedNCT00051532Not applicable
• Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate AcneCompletedNCT00031096Phase 3

← LEO Pharma overview and focus areas